Impaired BCR mediated B-cell activation likely contributes to the antibody deficiency in TTD1 deficient patients, however it is not excluded that the previously reported defects in inborn immunity and T-cell functions might also contribute to impaired antibody production in ERCC2 deficiency. Here, ERCC2 is linked to agammaglobulinemia.